A team at the University of Hong Kong (HKU) is embarking on a study to refine an artificial intelligence (AI) tool designed to predict the risk of cardiovascular disease. The "Heartwise" study aims to enroll 3,000 patients to enhance the accuracy of the "P-Cardiac" tool, marking a significant step in personalized cardiovascular risk assessment.
P-Cardiac: An AI-Driven Approach
The "P-Cardiac" tool, developed by HKU's Li Ka Shing Faculty of Medicine, leverages AI to evaluate a patient's likelihood of developing cardiovascular disease. This innovative tool accesses a vast database comprising 300,000 patient records from the Hospital Authority, representing one of the largest patient record repositories in Asia. By analyzing this extensive dataset, "P-Cardiac" aims to provide more accurate and individualized risk predictions.
The Heartwise Study: Recruitment and Goals
The upcoming recruitment round for the "Heartwise" study signifies a crucial phase in the development of "P-Cardiac." Clinical Professor Yiu Kai-hang, from the cardiology division of HKU's department of medicine, expressed optimism about the study's potential impact. "The findings have the potential to improve cardiovascular disease risk assessment, enhance primary and secondary prevention strategies, and promote personalised healthcare," said Yiu.
Implications for Cardiovascular Care
Cardiovascular diseases are a leading cause of mortality worldwide, making early and accurate risk assessment paramount. The "P-Cardiac" tool, with its AI-driven approach, offers a promising avenue for improving risk stratification and tailoring preventive interventions. By incorporating data from a large and diverse patient population, the tool has the potential to address the limitations of traditional risk assessment models and contribute to more effective cardiovascular disease management.
